Literature DB >> 19394256

Deficiency in N-acetylgalactosamine-6-sulfate sulfatase results in collagen perturbations in cartilage of Morquio syndrome A patients.

Ruud A Bank1, Johanna E M Groener, Justus J van Gemund, Petra D Maaswinkel, Kees A Hoeben, Herman A Schut, Vincent Everts.   

Abstract

AIM: To investigate extracellular matrix (ECM) characteristics of cortical bone and articular cartilage of patients with Morquio syndrome A, a lysosomal storage disease caused by a deficiency of N-acetylgalactosamine-6-sulfate sulfatase. PATIENTS AND METHODS: Cartilage, bone, and fibroblasts from 2 unrelated patients with Morquio syndrome were used. Histological analysis on bone and cartilage was carried out by means of light and electron microscopy. Lysyl hydroxylation and cross-linking of collagen present in bone, cartilage, and fibroblast cultures was determined by reverse-phase high performance liquid chromatography.
RESULTS: No histological or biochemical differences were seen in cortical bone; furthermore, no differences were seen in the amount and modification of collagen deposited by fibroblasts. Articular cartilage showed major differences: collagen fibrils show a wider range of fibril diameter, the fibrils are in mean thicker, the lysyl hydroxylation level of the triple helix is strongly decreased, the total amount of pyridinolines is in the lower ranges, and the ratio hydroxylysylpyridinoline to lysylpyridinoline is decreased. Changes were also observed with respect to the arrangement of proteoglycans in the extracellular matrix surrounding the chondrocytes.
CONCLUSION: The collagen of bone and the collagen deposited by fibroblasts is normal, whereas the ECM of cartilage in Morquio syndrome A patients is affected. Thus, deficiency in N-acetylgalactosamine-6-sulfate sulfatase has an impact on the phenotypic properties of chondrocytes, resulting in the formation of cartilage that is more prone to degeneration, being an explanation for the occurrence of osteoarthritis in Morquio syndrome A patients at early age.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19394256     DOI: 10.1016/j.ymgme.2009.03.008

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  13 in total

1.  Outcomes from 18 years of cervical spine surgery in MPS IVA: a single centre's experience.

Authors:  A Broomfield; K Zuberi; J Mercer; G Moss; N Finnegan; P Hensman; R Walker; S Bukhari; N B Wright; F Stewart; S A Jones; R Ramirez
Journal:  Childs Nerv Syst       Date:  2018-06-26       Impact factor: 1.475

2.  Pain: a prevalent feature in patients with mucopolysaccharidosis. Results of a cross-sectional national survey.

Authors:  Marion M G Brands; Deniz Güngör; Johanna M P van den Hout; Francois P J Karstens; Esmee Oussoren; Iris Plug; Jaap Jan Boelens; Peter M van Hasselt; Carla E M Hollak; Margot F Mulder; Estela Rubio Gozalbo; Jan A Smeitink; G Peter A Smit; Frits A Wijburg; Hanka Meutgeert; Ans T van der Ploeg
Journal:  J Inherit Metab Dis       Date:  2014-07-22       Impact factor: 4.982

3.  Analysis of microarchitectural changes in a mouse temporomandibular joint osteoarthritis model.

Authors:  J Chen; T Gupta; J A Barasz; Z Kalajzic; W-C Yeh; H Drissi; A R Hand; S Wadhwa
Journal:  Arch Oral Biol       Date:  2009-11-06       Impact factor: 2.633

4.  Therapies of mucopolysaccharidosis IVA (Morquio A syndrome).

Authors:  Shunji Tomatsu; Carlos J Alméciga-Díaz; Hector Barbosa; Adriana M Montaño; Luis A Barrera; Tsutomu Shimada; Eriko Yasuda; William G Mackenzie; Robert W Mason; Yasuyuki Suzuki; Kenji E Orii; Tadao Orii
Journal:  Expert Opin Orphan Drugs       Date:  2013-10-01       Impact factor: 0.694

5.  Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice.

Authors:  Melita Dvorak-Ewell; Dan Wendt; Chuck Hague; Terri Christianson; Vish Koppaka; Danielle Crippen; Emil Kakkis; Michel Vellard
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

6.  Overcoming the barriers to diagnosis of Morquio A syndrome.

Authors:  Kaustuv Bhattacharya; Shanti Balasubramaniam; Yew Sing Choy; Michael Fietz; Antony Fu; Dong Kyu Jin; Ok-Hwa Kim; Motomichi Kosuga; Young Hee Kwun; Anita Inwood; Hsiang-Yu Lin; Jim McGill; Nancy J Mendelsohn; Torayuki Okuyama; Hasri Samion; Adeline Tan; Akemi Tanaka; Verasak Thamkunanon; Teck-Hock Toh; Albert D Yang; Shuan-Pei Lin
Journal:  Orphanet J Rare Dis       Date:  2014-11-30       Impact factor: 4.123

7.  Natural history of Morquio A patient with tracheal obstruction from birth to death.

Authors:  Caitlin Doherty; Lauren W Averill; Mary Theroux; William G Mackenzie; Christian Pizarro; Robert W Mason; Shunji Tomatsu
Journal:  Mol Genet Metab Rep       Date:  2017-12-22

Review 8.  Minimal clinically important difference for the 6-min walk test: literature review and application to Morquio A syndrome.

Authors:  Rudolf Schrover; Kathryn Evans; Roberto Giugliani; Ian Noble; Kaustuv Bhattacharya
Journal:  Orphanet J Rare Dis       Date:  2017-04-26       Impact factor: 4.123

9.  Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance.

Authors:  Mehmet Umut Akyol; Tord D Alden; Hernan Amartino; Jane Ashworth; Kumar Belani; Kenneth I Berger; Andrea Borgo; Elizabeth Braunlin; Yoshikatsu Eto; Jeffrey I Gold; Andrea Jester; Simon A Jones; Cengiz Karsli; William Mackenzie; Diane Ruschel Marinho; Andrew McFadyen; Jim McGill; John J Mitchell; Joseph Muenzer; Torayuki Okuyama; Paul J Orchard; Bob Stevens; Sophie Thomas; Robert Walker; Robert Wynn; Roberto Giugliani; Paul Harmatz; Christian Hendriksz; Maurizio Scarpa
Journal:  Orphanet J Rare Dis       Date:  2019-06-13       Impact factor: 4.123

10.  Orthopedic management of the extremities in patients with Morquio A syndrome.

Authors:  Klane K White; Andrea Jester; C Edward Bache; Paul R Harmatz; Renée Shediac; Mihir M Thacker; William G Mackenzie
Journal:  J Child Orthop       Date:  2014-07-08       Impact factor: 1.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.